Science
Mechanism of Action
This ingredient operates by inhibiting critical enzymes involved in melanogenesis and disrupting the cAMP-phosphokinase A-cAMP response element-binding protein signaling pathway. This dual action leads to a reduction in melanin synthesis within the skin, thereby lessening the appearance of hyperpigmentation.
Research
Clinical Evidence
Medium confidence0.5%
Transparency
Dusting Analysis
The Formula
Formulation
Safety
Safety Profile
While comprehensive GHS classifications and full toxicity profiles (oral, parenteral, dermal, inhalation) are not readily available, a clinical study at 0.5% concentration indicated good tolerability in human subjects. The substance is listed in the FDA Global Substance Registration System (GSRS).
Your Skin
Skin Compatibility
Our Assessment
Verdict
ADAMANTANYL HYDROXYBENZAMIDE is a valuable ingredient for addressing hyperpigmentation, demonstrated effective at 0.5% and well tolerated in clinical settings, though further comprehensive safety data would enhance its profile.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources